Chronic hypoxemia is a common manifestation of pulmonary disease as well as of exposure of healthy individuals to the reduced barometric pressure of high altitude. Although the effects of acute hypoxic exposure on cardiovascular control have been described, little is known of the effect of chronic hypoxemia on neurohumoral control of the cardiovascular system. Preliminary data from our laboratory suggest that prolonged hypoxemia may elicit attenuated vasoreactive responses to major pressor stimuli, as well as altered arterial baroreflex function. Both of these responses could greatly alter the efficacy of cardiovascular control under these clinically relevant conditions. The present application is designed to extend our pilot observations and to attempt to define the mechanisms involved in hypoxia-induced alterations in cardiovascular function using both in vivo and in vitro approaches. Specific goals of the project are: 1) To determine whether the observed attenuation in systemic vasoreactivity to alpha-agonist, vasopressin, or angiotensin II administration is present selectively in different vascular beds of the conscious chronically instrumented animal. 2) To test whether a portion of the attenuated pressor response in chronically hypoxemic animals is due to augmented arterial baroreflex function. 3) To examine the in vitro responses of arteries from chronically hypoxic animals to determine if the attenuated responsiveness to pressor agonists may be due to a common effect on vascular smooth muscle. Since our pilot data indicate that diminished responsiveness to pressor agonists is demonstrable in aortic rings from chronically hypoxic rats, the next specific aims will address possible mechanisms for that attenuation, such as: 4) To examine the possibility that vascular smooth muscle contraction is attenuated due to increased release of vasodilatory modulators such as endothelium derived relaxing factor, prostacyclin or adenosine. 5) To test whether there is a reduction in agonist receptor number or affinity in chronically hypoxic rats. 6) To test whether chronic hypoxia affects intracellular signal transduction within vascular smooth muscle cells, thereby reducing agonist- induced contraction. The experiments in the proposal utilize both in vitro preparations and conscious animals, and are designed such that positive findings in the in vitro experiments will be corroborated where possible in the intact animal. This approach allows determination of the significance of putative cellular mechanisms in the integrated response to hypoxemia by the whole animal.

Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of New Mexico
Department
Type
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Bharadwaj, D; Mold, C; Markham, E et al. (2001) Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J Immunol 166:6735-41
Romero, I R; Morris, C; Rodriguez, M et al. (1998) Inflammatory potential of C-reactive protein complexes compared to immune complexes. Clin Immunol Immunopathol 87:155-62
Tetzloff, S U; Bizzozero, O A (1998) Palmitoylation of proteolipid protein from rat brain myelin using endogenously generated 18O-fatty acids. J Biol Chem 273:279-85
Sanchez, P; Tetzloff, S U; Bizzozero, O A (1998) Veratridine-induced depolarization reduces the palmitoylation of brain and myelin glycerolipids. J Neurochem 70:1448-57
Bryant, J E; Hutchings, K G; Moyzis, R K et al. (1997) Measurement of telomeric DNA content in human tissues. Biotechniques 23:476-8, 480, 482, passim
Melendez, R F; Bizzozero, O A (1996) Palmitoylation of myelin P0 protein is independent of its synthesis and parallels that of phospholipids. J Peripher Nerv Syst 1:34-41
Mold, C; Gurule, C; Otero, D et al. (1996) Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1. Clin Immunol Immunopathol 81:153-60
Chapin, J E; Davis, L E; Kornfeld, M et al. (1995) Neurologic manifestations of intravascular lymphomatosis. Acta Neurol Scand 91:494-9
Smith, J P; Hicks, P S; Ortiz, L R et al. (1995) Quantitative measurement of muscle strength in the mouse. J Neurosci Methods 62:15-9
Varela, M F; Sansom, C E; Griffith, J K (1995) Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamily. Mol Membr Biol 12:313-9

Showing the most recent 10 out of 18 publications